Genetic Technologies Ltd - American Depositary Shares (GENE)
0.7650
+0.00 (0.00%)
NASDAQ · Last Trade: Apr 2nd, 10:26 PM EDT
Detailed Quote
Previous Close | 0.7650 |
---|---|
Open | - |
Bid | 0.7650 |
Ask | 0.8000 |
Day's Range | N/A - N/A |
52 Week Range | 0.6666 - 3.590 |
Volume | 0 |
Market Cap | - |
PE Ratio (TTM) | - |
EPS (TTM) | - |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | - |
About Genetic Technologies Ltd - American Depositary Shares (GENE)
Genetic Tech Spn is a biotechnology company that focuses on leveraging genetic research and advanced molecular technologies to develop innovative diagnostic and therapeutic solutions. The company’s mission centers around improving healthcare outcomes through personalized medicine, by utilizing insights derived from genetic data to inform clinical decisions and treatment plans. It actively works on a range of genetic testing services and therapeutics, aiming to address various health conditions and enhance patient care by offering tailored solutions that target the unique genetic profiles of individuals. Read More
News & Press Releases

Via Benzinga · October 14, 2024

ORLANDO, FL / ACCESSWIRE / October 11, 2024 / RedChip Companies will air interviews with BioVie, Inc. (Nasdaq:BIVI) and Genetic Technologies Limited (Nasdaq:GENE)(ASX:GTG) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, October 12, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.
Via ACCESSWIRE · October 11, 2024

Via Benzinga · September 19, 2024

Via Benzinga · September 18, 2024

Via Benzinga · August 26, 2024

Via Benzinga · July 26, 2024

MELBOURNE, Australia, July 16, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness, and serious disease, is pleased to announce the appointment of Mark Ziirsen as Chief Financial Officer (CFO) and Company Secretary.
By Genetic Technologies Ltd · Via GlobeNewswire · July 16, 2024